SEC FORM 3

Please wait

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Rogers Campbell

(Last)

(First)

(Middle)

C/O HEARTFLOW, INC.

331 E. EVELYN AVENUE

(Street)

MOUNTAIN VIEW

94041

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/07/2025

3. Issuer Name and Ticker or Trading Symbol
Heartflow, Inc. [ HTFL ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Medical Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	22,615⁽¹⁾	I	By Campbell Rogers 2019 Irrevocable Trust
Common Stock	46,159⁽¹⁾	I	By CR Asset Protection Trust of 2023
Common Stock	26,012⁽¹⁾	I	By Spouse's Trust
Common Stock	50,754⁽¹⁾	I	By The Campbell Rogers Revocable Trust

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option	⁽²⁾	03/09/2026	Common Stock	39,709⁽¹⁾	$8.33⁽¹⁾	D
Stock Option	⁽²⁾	02/28/2030	Common Stock	43,785⁽¹⁾	$8.33⁽¹⁾	D
Stock Option	⁽²⁾	04/22/2030	Common Stock	2,231⁽¹⁾	$8.33⁽¹⁾	D
Stock Option	⁽²⁾	04/12/2031	Common Stock	3,589⁽¹⁾	$8.33⁽¹⁾	D
Stock Option	⁽³⁾	07/10/2033	Common Stock	235,834⁽¹⁾	$2.22⁽¹⁾	D
Stock Option	⁽²⁾	07/10/2033	Common Stock	6,849⁽¹⁾	$2.22⁽¹⁾	D

Explanation of Responses:

1. The number of shares of common stock and exercise price, as applicable, give effect to the 1-for-2.92 reverse stock split of Heartflow, Inc.'s common stock, which became effective on July 31, 2025.

2. These stock options are fully exercisable.

3. The option is vested and exercisable as to 118,494 shares, and the remaining shares will vest and become exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date.

Remarks:

Exhibit 24 - Power of Attorney.

	/s/ Angela Ahmad, Attorney-in-Fact for Campbell D.K. Rogers, M.D.	08/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.